01 / Contract Profile
HHSN272201600045C Federal Contract Award
Agency code 7529
EO14042: VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
HHSN272201600045C contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$0
FY 2021Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2016 | $142.9K | 1 | — |
| FY 2017 | $6.41M | 3 | +4,386.6% |
| FY 2018 | $768.8K | 1 | −88.0% |
| FY 2019 | $5.00M | 2 | +550.3% |
| FY 2020 | -$40 | 2 | −100.0% |
| FY 2021 | $0 | 1 | +100.0% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH NIAID |
05 / Contractor
Who holds this federal contract?
PORTON BIOPHARMA LIMITED
UEI CFB4MNCYT5A3 · CAGE U12B5
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541711 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | $12.32M | 10 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN13 | R&D- MEDICAL: BIOMEDICAL (ADVANCED DEVELOPMENT) | $12.32M | 10 | 100.0% |
08 / Place of Performance
Where is the work recorded?
UNITED KINGDOM
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Nov 14, 2021 | P00009 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541711 | AN13 |
| Mar 31, 2020 | P00008 | -$40 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541711 | AN13 |
| Jan 7, 2020 | P00007 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541711 | AN13 |
| Sep 5, 2019 | P00006 | $4.55M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541711 | AN13 |
| Apr 8, 2019 | P00005 | $450.3K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541711 | AN13 |
| Aug 1, 2018 | 4 | $768.8K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541711 | AN13 |
| Jul 16, 2017 | 3 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541711 | AN13 |
| May 23, 2017 | 2 | $5.60M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541711 | AN13 |
| Jan 12, 2017 | 1 | $814.0K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541711 | AN13 |
| Nov 16, 2016 | Base action | $142.9K | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541711 | AN13 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.